Showing 35,310 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined aidsmap in 2008 and was Managing Editor from 2018 to 2024. As a freelancer, he now edits aidsmap’s news and conference coverage, as well as working on updates to About HIV pages. He is also a contributing science editor for TheBodyPro, a freelance journalist for The Lancet HIV, and a medical writer helping researchers prepare articles for peer-reviewed journals. He began working on HIV at Gay Men Fighting AIDS in the mid-1990s.

HIV testing policies & guidelines

HIV tests for GPs' new patients could save lives and money, says study

Editor's pick
The Guardian
31 July 2017
New & experimental hepatitis C treatment

European Commission Grants AbbVie's MAVIRET® (glecaprevir/pibrentasvir) Marketing Authorization for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)

Editor's pick
AbbVie press release
31 July 2017
New & experimental hepatitis C treatment

European Commission Grants Marketing Authorization for Gilead’s Vosevi® (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Genotypes of Chronic Hepatitis C

Editor's pick
Gilead press release
31 July 2017
Chemsex & recreational drug use

Don’t Believe the Hype: The New Drugs Strategy Ignores the LGBT Community

Editor's pick
Vice
29 July 2017
PrEP

France’s next PrEP study aims to assess the wider impact of PrEP on the HIV epidemic

News
28 July 2017
PrEP programmes & uptake

Dutch study finds out whether gay men prefer daily or on-demand PrEP

News
28 July 2017
Hepatitis C treatment

From chronic to cured: could Australia be the first country in the world to eliminate hep C?

Editor's pick
Kirby Institute
28 July 2017
PrEP

Philippines trials anti-HIV drug as cases hit record high

Editor's pick
Thomson Reuters
27 July 2017
Global health targets

HIV treatment: Strategies to reach the next 10 million patients

Editor's pick
Devex
27 July 2017
Side effects

New Data Shows Dramatic Reduction in Chronic Diarrhea Episodes with Crofelemer (Mytesi) Treatment

Editor's pick
Napo Pharmaceuticals press release
27 July 2017
Vaginal rings & topical PrEP

Dapivirine vaginal ring safe, acceptable for HIV prevention in teens

Editor's pick
Healio
27 July 2017
Self-testing & home testing

IAS 2017: UNITAID, partners boost HIV self-test access in six African countries

Editor's pick
Science Speaks
27 July 2017
Pregnancy and vertical transmission

Vertical HIV transmission may be influenced by complex synergies with other STI – such as Cytomegalovirus

Editor's pick
BMJ Group blogs
27 July 2017
Hepatitis & HIV

ECDC estimate: Around 9 million Europeans are affected by chronic hepatitis B or C

Editor's pick
Eurekalert Inf Dis
27 July 2017
Vaginal rings & topical PrEP

Rectal products for PrEP: Are they an option?

Editor's pick
BETA blog
27 July 2017
The search for a cure

What can science learn from a child who has controlled HIV without drugs for more than 8 years?

Editor's pick
Science
27 July 2017
Injectable & long-acting PrEP

Long-acting cabotegravir injection shows promise for HIV prevention

News
27 July 2017
New & experimental HIV treatments

Doravirine combination pill looks good for initial HIV treatment

News
27 July 2017
Side effects

Acute kidney injury ‘uncommon’ but unpredictable on tenofovir and ritonavir

News
27 July 2017
Access to healthcare

Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows

News
27 July 2017
PrEP

Update on PrEP Impact trial in England

Editor's pick
Gov.uk
26 July 2017
Circumcision

Medical male circumcision for HIV has benefits for women too

News
26 July 2017
PrEP

Demonstration projects explore the feasibility of PrEP for adolescents and young women in South Africa

News
26 July 2017
Drug-resistant TB

X-DR TB emerged in 1990s in South Africa fueled by HIV

Editor's pick
Science Speaks
26 July 2017